APOLIPOPROTEIN-E POLYMORPHISMS AFFECT ATHEROSCLEROSIS IN YOUNG MALES

被引:254
|
作者
HIXSON, JE
机构
[1] SW Found. for Biomedical Research, San Antonio, TX 78228-0147
来源
ARTERIOSCLEROSIS AND THROMBOSIS | 1991年 / 11卷 / 05期
关键词
APOLIPOPROTEIN-E; ISOFORMS; SERUM CHOLESTEROL; LIPOPROTEIN CHOLESTEROL; ATHEROSCLEROSIS; ABDOMINAL AORTA; THORACIC AORTA; RIGHT CORONARY ARTERY;
D O I
10.1161/01.ATV.11.5.1237
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Investigators in eight communities collected aortas, right coronary arteries, blood and liver samples, and associated information from 720 young males, aged 15-34 years, who died of external causes. Genotypes for apolipoprotein (apo) E isoforms (E2, E3, and E4) were determined from hepatic DNA by restriction isotyping (restriction enzyme isoform genotyping) of amplified apo E sequences. Pathologists graded the arteries for atherosclerotic lesions, and a central laboratory measured lipoprotein cholesterol concentrations. Allele frequencies were different between blacks and whites (p < 0.0001). E2 and E4 frequencies were higher and E3 frequency was lower in blacks than in whites. Among the common genotypes in both whites and blacks, E2E3 heterozygotes had the lowest levels of total serum cholesterol and low density lipoproteins, E3E4 had the highest levels, and E3E3 had intermediate levels. Apo E genotypes differed in mean percent surface area involvement with lesions in the thoracic aorta and the abdominal aorta of both whites and blacks (p less-than-or-equal-to 0.0002). Among the common genotypes, E2E3 heterozygotes had the least involvement of both thoracic and abdominal aortas with lesions, E3E4 had the greatest involvement (with the exception of the thoracic aorta in whites), and E3E3 had intermediate involvement. Apo E genotype accounted for 5.7% in whites and 5.9% in blacks of the observed variation in lesions for the thoracic aorta, and for 5.9% in whites and 7.0% in blacks for the abdominal aorta. Adjusting for cholesterol levels did not change apo E genotypic effects appreciably, an observation suggesting that genotypic effects on arterial lesions may not be mediated entirely by changes in serum cholesterol concentrations.
引用
收藏
页码:1237 / 1244
页数:8
相关论文
共 50 条
  • [21] APOLIPOPROTEIN-E IN ABETALIPOPROTEINEMIA
    BLUM, CB
    DECKELBAUM, R
    WITTE, L
    FAINARU, M
    ARTERIOSCLEROSIS, 1981, 1 (01): : 81 - 81
  • [22] Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice
    Hsich, E
    Zhou, YF
    Paigen, B
    Johnson, TM
    Burnett, MS
    Epstein, SE
    ATHEROSCLEROSIS, 2001, 156 (01) : 23 - 28
  • [23] Beneficial effect of cilostazol on atherosclerosis development in Apolipoprotein-E knockout mice
    Takase, H.
    Hashimoto, A.
    Okutsu, R.
    Hirose, Y.
    Ito, H.
    Imaizumi, T.
    Miyakoda, G.
    Mori, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 394 - 394
  • [24] APOLIPOPROTEIN-E IN HYPERLIPIDEMIA
    WALDEN, CC
    HEGELE, RA
    ANNALS OF INTERNAL MEDICINE, 1994, 120 (12) : 1026 - 1036
  • [25] APOLIPOPROTEIN-E IN ABETALIPOPROTEINEMIA
    BLUM, CB
    DECKELBAUM, R
    WITTE, L
    FAINARU, M
    CIRCULATION, 1980, 62 (04) : 43 - 43
  • [26] NONINVASIVE ASSESSMENT OF ATHEROSCLEROSIS IN APOLIPOPROTEIN-E KNOCKOUT MICE BY ULTRASOUND BIOMICROSCOPY
    Wang, Yanhong
    Yang, Ya
    Xie, Jinjie
    Li, Zhian
    Zhang, Xiaoshan
    Li, Rongjuan
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2011, 37 (06): : 892 - 899
  • [27] APOLIPOPROTEIN-E AND ALZHEIMERS
    VANBOCKXMEER, FM
    NATURE, 1995, 375 (6529) : 285 - 285
  • [28] APOLIPOPROTEIN-E AND AMYLOIDOGENESIS
    CASTANO, EM
    PRELLI, FC
    FRANGIONE, B
    LABORATORY INVESTIGATION, 1995, 73 (04) : 457 - 460
  • [29] THE APOLIPOPROTEIN-E CONNECTION
    UTERMANN, G
    CURRENT BIOLOGY, 1994, 4 (04) : 362 - 365
  • [30] APOLIPOPROTEIN-E PREVENTS THE PROGRESSION OF ATHEROSCLEROSIS IN WATANABE HERITABLE HYPERLIPIDEMIC RABBITS
    YAMADA, N
    INOUE, I
    KAWAMURA, M
    HARADA, K
    WATANABE, Y
    SHIMANO, H
    GOTODA, T
    SHIMADA, M
    KOHZAKI, K
    TSUKADA, T
    SHIOMI, M
    WATANABE, Y
    YAZAKI, Y
    JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (02): : 706 - 711